Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RV3-BB vaccine efficacy trial in newborn infants
ACTRN12612001282875Phase 2Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jan 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RV3-BB rotavirus vaccine in rotaviral diarrhea (3 arms), sponsored by Murdoch Children's Research Institute. Primary endpoint: Episodes of severe rotavirus gastroenteritis. Started Jan 2013; status: completed.
02
Drugs
RV3-BB rotavirus vaccine
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on ACTRN12612001282875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001282875.